2025年12月2日，康灃生物科技（上海）股份有限公司（06922）公布截至2025年11月30日的股份变动月报表。报告期内，公司注册股本总额维持在人民币239,110,000元，其中H股143,438,579股，非上市股份95,671,421股，面值均为每股人民币1元。截至本月底，上述各类股份的已发行数量均无新增发行或回购注销活动。
\n\n公司进一步披露，没有处置或授出任何股份期权、可换股票据及其他可承诺发行股份的权益。截至2025年11月末，公司股本结构未发生变化，整体维持稳定。
\n\n公司确认已遵守香港联合交易所有限公司《上市规则》及相关法规。该公告由公司董事朱军签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.